Cita APA

Pirolli, R., de Alencar, V. T. L., Estati, F. L., Ribeiro, A. R. G., Honda, D. Y. T., de Oliveira, M., . . . da Costa, A. A. B. A. (2021). Comparison of dose-dense vs. 3-weekly paclitaxel and carboplatin in the first-line treatment of ovarian cancer in a propensity score-matched cohort. BMC Cancer.

Chicago Style Citation

Pirolli, Rafaela, et al. "Comparison of Dose-dense Vs. 3-weekly Paclitaxel and Carboplatin in the First-line Treatment of Ovarian Cancer in a Propensity Score-matched Cohort." BMC Cancer 2021.

Cita MLA

Pirolli, Rafaela, et al. "Comparison of Dose-dense Vs. 3-weekly Paclitaxel and Carboplatin in the First-line Treatment of Ovarian Cancer in a Propensity Score-matched Cohort." BMC Cancer 2021.